Role of glioblastoma stem cells in cancer therapeutic resistance: a perspective on antineoplastic agents from natural sources and chemical derivatives
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of glioblastoma stem cells in cancer therapeutic resistance: a perspective on antineoplastic agents from natural sources and chemical derivatives
Authors
Keywords
-
Journal
Stem Cell Research & Therapy
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-03-24
DOI
10.1186/s13287-021-02231-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas
- (2020) Daniel J. Brat et al. ACTA NEUROPATHOLOGICA
- Metformin as Potential Therapy for High-Grade Glioma
- (2020) Marek Mazurek et al. Cancers
- Glioblastoma chemotherapeutic agents used in the clinical setting and in clinical trials: Nanomedicine approaches to improve their efficacy
- (2020) Juan Aparicio-Blanco et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Inhibition of TFEB oligomerization by co-treatment of melatonin with vorinostat promotes the therapeutic sensitivity in glioblastoma and glioma stem cells
- (2019) Gi-Jun Sung et al. JOURNAL OF PINEAL RESEARCH
- Inhibition of ATM kinase upregulates levels of cell death induced by cannabidiol and γ-irradiation in human glioblastoma cells
- (2019) Vladimir N. Ivanov et al. Oncotarget
- Characterizing Eckol as a Therapeutic Aid: A Systematic Review
- (2019) Bandana Manandhar et al. Marine Drugs
- Cancer Stem Cells and Radioresistance: DNA Repair and Beyond
- (2019) Alexander Schulz et al. Cancers
- A Comprehensive Review of Autophagy and Its Various Roles in Infectious, Non-Infectious, and Lifestyle Diseases: Current Knowledge and Prospects for Disease Prevention, Novel Drug Design, and Therapy
- (2019) Rekha Khandia et al. Cells
- New Insights Into Implementation of Mesenchymal Stem Cells in Cancer Therapy: Prospects for Anti-angiogenesis Treatment
- (2019) Mohammad Reza Javan et al. Frontiers in Oncology
- Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets
- (2019) Olivia G. Taylor et al. Frontiers in Oncology
- The Chk1 inhibitor SAR-020106 sensitizes human glioblastoma cells to irradiation, to temozolomide, and to decitabine treatment
- (2019) Ina Patties et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016
- (2019) Quinn T Ostrom et al. NEURO-ONCOLOGY
- Inhibition of Casein Kinase II by CX-4945, But Not Yes-associated protein (YAP) by Verteporfin, Enhances the Antitumor Efficacy of Temozolomide in Glioblastoma
- (2019) Xiangyu Liu et al. Translational Oncology
- mTOR-Mediated Antioxidant Activation in Solid Tumor Radioresistance
- (2019) Yunseo Woo et al. Journal of Oncology
- Concurrent Inhibition of Neurosphere and Monolayer Cells of Pediatric Glioblastoma by Aurora A Inhibitor MLN8237 Predicted Survival Extension in PDOX Models
- (2018) Mari Kogiso et al. CLINICAL CANCER RESEARCH
- The CNS penetrating taxane TPI 287 and the AURKA inhibitor alisertib induce synergistic apoptosis in glioblastoma cells
- (2018) Cory T. Zumbar et al. JOURNAL OF NEURO-ONCOLOGY
- Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide
- (2018) Israel López-Valero et al. BIOCHEMICAL PHARMACOLOGY
- CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015
- (2018) Quinn T Ostrom et al. NEURO-ONCOLOGY
- Inhibition of autophagy increases susceptibility of glioblastoma stem cells to temozolomide by igniting ferroptosis
- (2018) Mariachiara Buccarelli et al. Cell Death & Disease
- Reproducibility of academic preclinical translational research: lessons from the development of Hedgehog pathway inhibitors to treat cancer
- (2018) Tom Curran Open Biology
- Autophagic flux response and glioblastoma sensitivity to radiation
- (2018) G. Mitrakas Achilleas et al. Cancer Biology & Medicine
- Re-purposing Chloroquine for Glioblastoma: Potential Merits and Confounding Variables
- (2018) Patrick Weyerhäuser et al. Frontiers in Oncology
- State-of-the-art strategies for targeting the DNA damage response in cancer
- (2018) Patrick G. Pilié et al. Nature Reviews Clinical Oncology
- PubChem 2019 update: improved access to chemical data
- (2018) Sunghwan Kim et al. NUCLEIC ACIDS RESEARCH
- Honokiol Eliminates Glioma/Glioblastoma Stem Cell-Like Cells Via JAK-STAT3 Signaling and Inhibits Tumor Progression by Targeting Epidermal Growth Factor Receptor
- (2018) Yipu Fan et al. Cancers
- Epidermal growth factor receptor in glioblastoma
- (2017) Hongsheng Xu et al. Oncology Letters
- Epidermal growth factor receptor activity is elevated in glioma cancer stem cells and is required to maintain chemotherapy and radiation resistance
- (2017) Lisa Y. Pang et al. Oncotarget
- Impact of STAT3 phosphorylation in glioblastoma stem cells radiosensitization and patient outcome
- (2017) Konstantin Masliantsev et al. Oncotarget
- HIF1α regulates single differentiated glioma cell dedifferentiation to stem-like cell phenotypes with high tumorigenic potential under hypoxia
- (2017) Pan Wang et al. Oncotarget
- RAD51 Is a Selective DNA Repair Target to Radiosensitize Glioma Stem Cells
- (2017) Harry O. King et al. Stem Cell Reports
- Therapeutic Potential for Bone Morphogenetic Protein 4 in Human Malignant Glioma
- (2017) Guifa Xi et al. NEOPLASIA
- Resveratrol Impairs Glioma Stem Cells Proliferation and Motility by Modulating the Wnt Signaling Pathway
- (2017) Chiara Cilibrasi et al. PLoS One
- Targeting glioma stem cells in vivo by a G-quadruplex-stabilizing synthetic macrocyclic hexaoxazole
- (2017) Takahiro Nakamura et al. Scientific Reports
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- A radiosensitizing effect of RAD51 inhibition in glioblastoma stem-like cells
- (2016) Anaïs Balbous et al. BMC CANCER
- Targeting autophagy to sensitive glioma to temozolomide treatment
- (2016) Yuanliang Yan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Immunohistochemical Analysis of ATRX, IDH1 and p53 in Glioblastoma and Their Correlations with Patient Survival
- (2016) Ajay Chaurasia et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- The role of microglia and macrophages in glioma maintenance and progression
- (2016) Dolores Hambardzumyan et al. NATURE NEUROSCIENCE
- Advances in the targeting of HIF-1α and future therapeutic strategies for glioblastoma multiforme
- (2016) Gang Wang et al. ONCOLOGY REPORTS
- PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma
- (2016) Xiaoman Li et al. Oncotarget
- Glioblastoma Stem Cells Microenvironment: The Paracrine Roles of the Niche in Drug and Radioresistance
- (2016) Alessia Fidoamore et al. Stem Cells International
- Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status
- (2015) Dawn Q Chong et al. BMC CANCER
- Genetic Classification of Gliomas: Refining Histopathology
- (2015) Michael B. Foote et al. CANCER CELL
- Selective Inhibition of Parallel DNA Damage Response Pathways Optimizes Radiosensitization of Glioblastoma Stem-like Cells
- (2015) S. U. Ahmed et al. CANCER RESEARCH
- Therapeutic strategies targeting cancer stem cells
- (2015) Go J. Yoshida et al. CANCER SCIENCE
- Molecular Pathways: Overcoming Radiation Resistance by Targeting DNA Damage Response Pathways
- (2015) M. A. Morgan et al. CLINICAL CANCER RESEARCH
- Cell Metabolism Under Microenvironmental Low Oxygen Tension Levels in Stemness, Proliferation and Pluripotency
- (2015) M.P. Miguel et al. CURRENT MOLECULAR MEDICINE
- Natural Products and Cancer Stem Cells
- (2015) Cristina Marucci et al. CURRENT PHARMACEUTICAL DESIGN
- Cancer stem cells in glioblastoma
- (2015) Justin D. Lathia et al. GENES & DEVELOPMENT
- Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
- (2015) Jeanette E. Eckel-Passow et al. NEW ENGLAND JOURNAL OF MEDICINE
- EGFRAmplification and Glioblastoma Stem-Like Cells
- (2015) Katrin Liffers et al. Stem Cells International
- Inhibition of multidrug resistance protein 1 (MRP1) improves chemotherapy drug response in primary and recurrent glioblastoma multiforme
- (2015) Amanda Tivnan et al. Frontiers in Neuroscience
- Hedgehog Signaling in the Maintenance of Cancer Stem Cells
- (2015) Catherine Cochrane et al. Cancers
- Elimination of Cancer Stem-Like Cells and Potentiation of Temozolomide Sensitivity by Honokiol in Glioblastoma Multiforme Cells
- (2015) I-Chun Lai et al. PLoS One
- The Brain Microenvironment Preferentially Enhances the Radioresistance of CD133+ Glioblastoma Stem-like Cells
- (2015) Muhammad Jamal et al. NEOPLASIA
- MiR-152 functions as a tumor suppressor in glioblastoma stem cells by targeting Krüppel-like factor 4
- (2014) Jun Ma et al. CANCER LETTERS
- Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy
- (2014) B Auffinger et al. CELL DEATH AND DIFFERENTIATION
- Glioblastoma Stem-Like Cells – Isolation, Biology and Mechanisms of Chemotherapy Resistance
- (2014) Iwona Ciechomska et al. Current Signal Transduction Therapy
- Hypoxia as a biomarker for radioresistant cancer stem cells
- (2014) Claudia Peitzsch et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- The expression of SALL4 in patients with gliomas: high level of SALL4 expression is correlated with poor outcome
- (2014) Lei Zhang et al. JOURNAL OF NEURO-ONCOLOGY
- Radiotherapy Followed by Aurora Kinase Inhibition Targets Tumor-Propagating Cells in Human Glioblastoma
- (2014) N. Li et al. MOLECULAR CANCER THERAPEUTICS
- Abrogation of radioresistance in glioblastoma stem-like cells by inhibition of ATM kinase
- (2014) Ross Carruthers et al. Molecular Oncology
- Changing value through cued approach: an automatic mechanism of behavior change
- (2014) Tom Schonberg et al. NATURE NEUROSCIENCE
- Current evidence of temozolomide and bevacizumab in treatment of gliomas
- (2014) Danop Nanegrungsunk et al. NEUROLOGICAL RESEARCH
- Casein kinase 2α regulates glioblastoma brain tumor-initiating cell growth through the β-catenin pathway
- (2014) R T Nitta et al. ONCOGENE
- Tanshinone IIA inhibits the growth, attenuates the stemness and induces the apoptosis of human glioma stem cells
- (2014) LIUQI YANG et al. ONCOLOGY REPORTS
- Glioma Stem Cells: Markers, Hallmarks and Therapeutic Targeting by Metformin
- (2014) Joseph Najbauer et al. PATHOLOGY & ONCOLOGY RESEARCH
- A Synthetic dl-Nordihydroguaiaretic acid (Nordy), Inhibits Angiogenesis, Invasion and Proliferation of Glioma Stem Cells within a Zebrafish Xenotransplantation Model
- (2014) Xiaojun Yang et al. PLoS One
- Differential sensitivity of Glioma stem cells to Aurora kinase A inhibitors: Implications for stem cell mitosis and centrosome dynamics
- (2014) Mariella Mannino et al. Stem Cell Research
- Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo
- (2014) M Signore et al. Cell Death & Disease
- STAT3 Activation in Glioblastoma: Biochemical and Therapeutic Implications
- (2014) Jennifer Kim et al. Cancers
- Glioblastomas are composed of genetically divergent clones with distinct tumourigenic potential and variable stem cell-associated phenotypes
- (2013) Daniel Stieber et al. ACTA NEUROPATHOLOGICA
- Pharmacokinetic characterization of CK2 inhibitor CX-4945
- (2013) You Hwa Son et al. ARCHIVES OF PHARMACAL RESEARCH
- Clinicopathological significance of expression of nestin, a neural stem/progenitor cell marker, in human glioma tissue
- (2013) Takehiro Tomita et al. Brain Tumor Pathology
- Hypoxia upregulates aldehyde dehydrogenase isoform 1 (ALDH1) expression and induces functional stem cell characteristics in human glioblastoma cells
- (2013) Eric Soehngen et al. Brain Tumor Pathology
- Melatonin-induced methylation of the ABCG2/BCRP promoter as a novel mechanism to overcome multidrug resistance in brain tumour stem cells
- (2013) V Martín et al. BRITISH JOURNAL OF CANCER
- Guggulsterone sensitizes glioblastoma cells to Sonic hedgehog inhibitor SANT-1 induced apoptosis in a Ras/NFκB dependent manner
- (2013) Deobrat Dixit et al. CANCER LETTERS
- Targeting Cancer Stem Cells for Treatment of Glioblastoma Multiforme
- (2013) Der-Yang Cho et al. CELL TRANSPLANTATION
- The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance
- (2013) Florian A. Siebzehnrubl et al. EMBO Molecular Medicine
- Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma
- (2013) TADASHI ASHIZAWA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Harmine hydrochloride inhibits Akt phosphorylation and depletes the pool of cancer stem-like cells of glioblastoma
- (2013) Huailei Liu et al. JOURNAL OF NEURO-ONCOLOGY
- Expansion of CD133-positive glioma cells in recurrent de novo glioblastomas after radiotherapy and chemotherapy
- (2013) Kaoru Tamura et al. JOURNAL OF NEUROSURGERY
- The mTORC1/mTORC2 inhibitor AZD2014 enhances the radiosensitivity of glioblastoma stem-like cells
- (2013) Jenna Kahn et al. NEURO-ONCOLOGY
- Inhibition of EGFR Induces a c-MET-Driven Stem Cell Population in Glioblastoma
- (2013) Hyun Jung Jun et al. STEM CELLS
- Repositioning metformin for cancer prevention and treatment
- (2013) Brendan J. Quinn et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Autophagy prevents irradiation injury and maintains stemness through decreasing ROS generation in mesenchymal stem cells
- (2013) J Hou et al. Cell Death & Disease
- Cyclopamine is a novel Hedgehog signaling inhibitor with significant anti-proliferative, anti-invasive and anti-estrogenic potency in human breast cancer cells
- (2013) JUN CHE et al. Oncology Letters
- Bevacizumab is an active agent for recurrent high-grade glioma, but do we need randomized controlled trials?
- (2012) Patrick G. Morris ANTI-CANCER DRUGS
- Glioblastoma cancer stem cells: Role of the microenvironment and therapeutic targeting
- (2012) Luca Persano et al. BIOCHEMICAL PHARMACOLOGY
- Glioblastoma: Therapeutic challenges, what lies ahead
- (2012) Flavia R.S. Lima et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Aurora A is differentially expressed in gliomas, is associated with patient survival in glioblastoma and is a potential chemotherapeutic target in gliomas
- (2012) Norman L. Lehman et al. CELL CYCLE
- Metformin selectively affects human glioblastoma tumor-initiating cell viability
- (2012) Roberto Würth et al. CELL CYCLE
- Telomestatin Impairs Glioma Stem Cell Survival and Growth through the Disruption of Telomeric G-Quadruplex and Inhibition of the Proto-oncogene,c-Myb
- (2012) Takeshi Miyazaki et al. CLINICAL CANCER RESEARCH
- First-in-Human, Phase I Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of RO5126766, a First-in-Class Dual MEK/RAF Inhibitor in Patients with Solid Tumors
- (2012) M. Martinez-Garcia et al. CLINICAL CANCER RESEARCH
- All-trans-retinoic acid inhibits growth of head and neck cancer stem cells by suppression of Wnt/β-catenin pathway
- (2012) Young Chang Lim et al. EUROPEAN JOURNAL OF CANCER
- Induction of cell-cycle arrest and apoptosis in glioblastoma stem-like cells by WP1193, a novel small molecule inhibitor of the JAK2/STAT3 pathway
- (2012) Ke Sai et al. JOURNAL OF NEURO-ONCOLOGY
- Acetate supplementation modulates brain histone acetylation and decreases interleukin-1β expression in a rat model of neuroinflammation
- (2012) Mahmoud L Soliman et al. Journal of Neuroinflammation
- Honokiol traverses the blood-brain barrier and induces apoptosis of neuroblastoma cells via an intrinsic bax-mitochondrion-cytochrome c-caspase protease pathway
- (2012) J.-W. Lin et al. NEURO-ONCOLOGY
- Synergistic anti-cancer mechanisms of curcumin and paclitaxel for growth inhibition of human brain tumor stem cells and LN18 and U138MG cells
- (2012) Md. Motarab Hossain et al. NEUROCHEMISTRY INTERNATIONAL
- Chloroquine or Chloroquine-PI3K/Akt Pathway Inhibitor Combinations Strongly Promote γ-Irradiation-Induced Cell Death in Primary Stem-Like Glioma Cells
- (2012) Elke Firat et al. PLoS One
- Resistance to EGF receptor inhibitors in glioblastoma mediated by phosphorylation of the PTEN tumor suppressor at tyrosine 240
- (2012) T. R. Fenton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metformin and cancer: from the old medicine cabinet to pharmacological pitfalls and prospects
- (2012) Arian Emami Riedmaier et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1α stability and MGMT expression
- (2012) L Persano et al. Cell Death & Disease
- Glioma-Initiating Cell Elimination by Metformin Activation of FOXO3 via AMPK
- (2012) Atsushi Sato et al. Stem Cells Translational Medicine
- Rapamycin induces differentiation of glioma stem/progenitor cells by activating autophagy
- (2012) Wen-Zhuo Zhuang et al. Chinese Journal of Cancer
- Histone deacetylase inhibitors SAHA and sodium butyrate block G1-to-S cell cycle progression in neurosphere formation by adult subventricular cells
- (2011) Qiong Zhou et al. BMC NEUROSCIENCE
- Autophagy in Brain Tumors: A New Target for Therapeutic Intervention
- (2011) Niroop Kaza et al. BRAIN PATHOLOGY
- Efficacy and pharmacokinetic/pharmacodynamic evaluation of the Aurora kinase A inhibitor MLN8237 against preclinical models of pediatric cancer
- (2011) Hernan Carol et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Targeting glioma stem cells: A novel framework for brain tumors
- (2011) Emanuela Binello et al. CANCER SCIENCE
- Induction of autophagy promotes differentiation of glioma-initiating cells and their radiosensitivity
- (2011) Wenzhuo Zhuang et al. INTERNATIONAL JOURNAL OF CANCER
- Microregional antitumor activity of a small-molecule hypoxia-inducible factor 1 inhibitor
- (2011) KIYOSHI OKAMOTO et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis
- (2011) Yi-Ping Yang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Chemoresistance of glioblastoma cancer stem cells - much more complex than expected
- (2011) Dagmar Beier et al. Molecular Cancer
- Unknown
- (2011) Ilya Ulasov et al. MOLECULAR MEDICINE
- Radioresistance of glioma stem cells: Intrinsic characteristic or property of the ‘microenvironment-stem cell unit’?
- (2011) Mariella Mannino et al. Molecular Oncology
- Cilengitide induces autophagy-mediated cell death in glioma cells
- (2011) S. L. Lomonaco et al. NEURO-ONCOLOGY
- Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition
- (2011) M Ying et al. ONCOGENE
- The Small Molecule, LLL12, Inhibits STAT3 Phosphorylation and Induces Apoptosis in Medulloblastoma and Glioblastoma Cells
- (2011) Sarah Ball et al. PLoS One
- Eckol suppresses maintenance of stemness and malignancies in glioma stem-like cells
- (2011) Kyung-Hwan Hyun et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Essential Gene Pathways for Glioblastoma Stem Cells: Clinical Implications for Prevention of Tumor Recurrence
- (2011) Kazunari Yamada et al. Cancers
- Brain Cancer Stem Cells: Current Status on Glioblastoma Multiforme
- (2011) Sabrina Facchino et al. Cancers
- Hypoxia Increases the Expression of Stem-Cell Markers and Promotes Clonogenicity in Glioblastoma Neurospheres
- (2010) Eli E. Bar et al. AMERICAN JOURNAL OF PATHOLOGY
- Knockdown of the DNA-dependent protein kinase catalytic subunit radiosensitizes glioma-initiating cells by inducing autophagy
- (2010) Wenzhuo Zhuang et al. BRAIN RESEARCH
- A Hierarchy of Self-Renewing Tumor-Initiating Cell Types in Glioblastoma
- (2010) Ruihuan Chen et al. CANCER CELL
- Targeted therapies of cancer: Angiogenesis inhibition seems not enough
- (2010) Ilse Roodink et al. CANCER LETTERS
- Acidic stress promotes a glioma stem cell phenotype
- (2010) A B Hjelmeland et al. CELL DEATH AND DIFFERENTIATION
- Drugs That Target the Stemness Pathways
- (2010) S. E. Bates CLINICAL CANCER RESEARCH
- Differentiation Therapy Exerts Antitumor Effects on Stem-like Glioma Cells
- (2010) B. Campos et al. CLINICAL CANCER RESEARCH
- Immunobiological Characterization of Cancer Stem Cells Isolated from Glioblastoma Patients
- (2010) T. Di Tomaso et al. CLINICAL CANCER RESEARCH
- STAT3 is essential for the maintenance of neurosphere-initiating tumor cells in patients with glioblastomas: A potential for targeted therapy?
- (2010) Claire Villalva et al. INTERNATIONAL JOURNAL OF CANCER
- Improved Intratumoral Oxygenation Through Vascular Normalization Increases Glioma Sensitivity to Ionizing Radiation
- (2010) Mackenzie C. McGee et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Hedgehog/GLI1 regulates IGF dependent malignant behaviors in glioma stem cells
- (2010) Antony Hsieh et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Accumulation of CD133-positive glioma cells after high-dose irradiation by Gamma Knife surgery plus external beam radiation
- (2010) Kaoru Tamura et al. JOURNAL OF NEUROSURGERY
- Brain tumor stem cells: The cancer stem cell hypothesis writ large
- (2010) Peter B. Dirks Molecular Oncology
- Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells
- (2010) Lucia Ricci-Vitiani et al. NATURE
- Glioblastoma stem-like cells give rise to tumour endothelium
- (2010) Rong Wang et al. NATURE
- mTOR signaling in glioblastoma: lessons learned from bench to bedside
- (2010) D. Akhavan et al. NEURO-ONCOLOGY
- An Inhibitor of Arachidonate 5-Lipoxygenase, Nordy, Induces Differentiation and Inhibits Self-Renewal of Glioma Stem-Like Cells
- (2010) Bin Wang et al. Stem Cell Reviews and Reports
- Vascular endothelial growth factor inhibitors in malignant gliomas
- (2010) Priscilla K. Brastianos et al. Targeted Oncology
- Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells
- (2009) Zhizhong Li et al. CANCER CELL
- Enhanced MDR1 Expression and Chemoresistance of Cancer Stem Cells Derived from Glioblastoma
- (2009) Eiichi Nakai et al. CANCER INVESTIGATION
- AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with In vitro and In vivo Antitumor Activity
- (2009) C. M. Chresta et al. CANCER RESEARCH
- Glioma Stem Cell Lines Expanded in Adherent Culture Have Tumor-Specific Phenotypes and Are Suitable for Chemical and Genetic Screens
- (2009) Steven M. Pollard et al. Cell Stem Cell
- PTEN/PI3K/Akt Pathway Regulates the Side Population Phenotype and ABCG2 Activity in Glioma Tumor Stem-like Cells
- (2009) Anne-Marie Bleau et al. Cell Stem Cell
- CD133+ Glioblastoma Stem-like Cells are Radiosensitive with a Defective DNA Damage Response Compared with Established Cell Lines
- (2009) A. M. McCord et al. CLINICAL CANCER RESEARCH
- STAT3 Regulation of Glioblastoma Pathogenesis
- (2009) Nuria la Iglesia et al. CURRENT MOLECULAR MEDICINE
- Limits of CD133 as a marker of glioma self-renewing cells
- (2009) Virginie Clément et al. INTERNATIONAL JOURNAL OF CANCER
- The induction of autophagy by γ-radiation contributes to the radioresistance of glioma stem cells
- (2009) Stephanie L. Lomonaco et al. INTERNATIONAL JOURNAL OF CANCER
- The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5
- (2009) Kasper M.A. Rouschop et al. JOURNAL OF CLINICAL INVESTIGATION
- Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study
- (2009) Evanthia Galanis et al. JOURNAL OF CLINICAL ONCOLOGY
- Honokiol-mediated Inhibition of PI3K/mTOR Pathway
- (2009) Courtney Crane et al. JOURNAL OF IMMUNOTHERAPY
- Tumor initiating cells in malignant gliomas: biology and implications for therapy
- (2009) Costas G. Hadjipanayis et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma
- (2009) David A. Reardon et al. JOURNAL OF NEURO-ONCOLOGY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Physiologic Oxygen Concentration Enhances the Stem-Like Properties of CD133+ Human Glioblastoma Cells In vitro
- (2009) A. M. McCord et al. MOLECULAR CANCER RESEARCH
- Comparative Analysis of DNA Repair in Stem and Nonstem Glioma Cell Cultures
- (2009) M. Ropolo et al. MOLECULAR CANCER RESEARCH
- The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
- (2009) Ulrich Wellner et al. NATURE CELL BIOLOGY
- Combination of N-(4-hydroxyphenyl) retinamide and genistein increased apoptosis in neuroblastoma SK-N-BE2 and SH-SY5Y xenografts
- (2009) S. Karmakar et al. NEUROSCIENCE
- A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients
- (2008) M. Schaich et al. ANNALS OF ONCOLOGY
- The selectivity of inhibitors of protein kinase CK2: an update
- (2008) Mario A. Pagano et al. BIOCHEMICAL JOURNAL
- G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer
- (2008) N Bucher et al. BRITISH JOURNAL OF CANCER
- Epigenetic-Mediated Dysfunction of the Bone Morphogenetic Protein Pathway Inhibits Differentiation of Glioblastoma-Initiating Cells
- (2008) Jeongwu Lee et al. CANCER CELL
- CXCR4 mediates the proliferation of glioblastoma progenitor cells
- (2008) Moneeb Ehtesham et al. CANCER LETTERS
- Temozolomide Preferentially Depletes Cancer Stem Cells in Glioblastoma
- (2008) D. Beier et al. CANCER RESEARCH
- Cancer Stem Cell Analysis and Clinical Outcome in Patients with Glioblastoma Multiforme
- (2008) R. Pallini et al. CLINICAL CANCER RESEARCH
- Epidermal Growth Factor Plays a Crucial Role in Mitogenic Regulation of Human Brain Tumor Stem Cells
- (2008) Akio Soeda et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Stem Cell–Related “Self-Renewal” Signature and High Epidermal Growth Factor Receptor Expression Associated With Resistance to Concomitant Chemoradiotherapy in Glioblastoma
- (2008) Anastasia Murat et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
- (2008) Michael D. Prados et al. JOURNAL OF CLINICAL ONCOLOGY
- Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients
- (2008) Mingyu Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- CD133 identifies perivascular niches in grade II–IV astrocytomas
- (2008) Karina Christensen et al. JOURNAL OF NEURO-ONCOLOGY
- Characterization of a side population of astrocytoma cells in response to temozolomide
- (2008) Constance Chua et al. JOURNAL OF NEUROSURGERY
- AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies
- (2008) S. D. Zabludoff et al. MOLECULAR CANCER THERAPEUTICS
- Molecular Mechanisms of the Combination of Retinoid and Interferon-gamma for Inducing Differentiation and Increasing Apoptosis in Human Glioblastoma T98G and U87MG Cells
- (2008) Arabinda Das et al. NEUROCHEMICAL RESEARCH
- Antitumor Activity of Rapamycin in a Phase I Trial for Patients with Recurrent PTEN-Deficient Glioblastoma
- (2008) Tim F Cloughesy et al. PLOS MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search